Letter to the EditorNkx2-4 Mutation Confers Resistance to EGFR–Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Sarcomatoid Carcinoma
Under an Elsevier user license
open archive
Cited by (0)
© 2019 International Association for the Study of Lung Cancer. Published by Elsevier Inc.